InChI
1S/C43H65FN6O10/c1-12-32-43(8)35(50(40(55)60-43)19-14-13-18-49-23-30(46-47-49)28-16-15-17-29(45)21-28)26(4)33(51)24(2)22-41(6,56-11)37(27(5)36(53)42(7,44)39(54)58-32)59-38-34(52)31(48(9)10)20-25(3)57-38/h15-17,21,23-27,31-32,34-35,37-38,52H,12-14,18-20,22,45H2,1-11H3/t24-,25-,26-,27+,31+,32-,34-,35-,37-,38+,41-,42-,43-/m1/s1
InChI key
IXXFZUPTQVDPPK-QIFQIIIXSA-N
SMILES string
O=C([C@@H](C[C@](C)([C@@H]([C@H](C1=O)C)O[C@]2([C@@H]([C@H](C[C@H](O2)C)N(C)C)O)[H])OC)C)[C@@H]([C@@H]3[C@](C)([C@H](OC([C@@]1(C)F)=O)CC)OC(N3CCCCN4C=C(N=N4)C5=CC(N)=CC=C5)=O)C
assay
≥95% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
−20°C
Quality Level
Biochem/physiol Actions
Solithromycin is an orally available, broad spectrum, and potent anti-microbial and anti-inflammatory macrolide/fluoroketolide that is effective against respiratory tract pathogens associated with CABP, including macrolide-resistant strains, compared with other available macrolides. Solithromycin significantly inhibits production of TNFα, CXCL8 and MMP9. Also Solithromycin inhibits NF-κB activity under conditions of oxidative stress. Solithromycin exhibits superior anti-microbial and anti-inflammatory activities and is a potential therapy for refractory COPD.
orally available, broad spectrum, and potent anti-microbial and anti-inflammatory macrolide/fluoroketolide
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Yoshiki Kobayashi et al.
The Journal of pharmacology and experimental therapeutics, 345(1), 76-84 (2013-01-30)
Macrolides are reported to reduce exacerbation of chronic inflammatory respiratory disease, such as chronic obstructive pulmonary disease (COPD), and also show anti-inflammatory effects in vitro and in vivo. However the anti-inflammatory efficacies of current macrolides are relatively weak. Here we
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持